More than 20 NHS trusts stop using Palantir waiting-list tools

On October 3, the Financial Times reported that more than 20 NHS trusts in England had stopped using Palantir waiting-list tools, based on its analysis of platform activity. The development followed sustained scrutiny of the £330 million Federated Data Platform contract and public objections to the processing of health information through a system supplied by a US technology company. For clients, formal data-location assurances do not resolve sovereignty risk when adoption, political legitimacy, vendor dependence and exit capability remain contested. Procurement teams should therefore test actual utilization, portability and termination readiness alongside GDPR compliance and contractual statements about control of the data.